Source: Annual Congress 2004 - Clinical and diagnostic problems in tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Zareiy, M. S. Mirsaeidi, D. S. Mansouri, M. Amiri, M. Kazempour, M. R. Masjedi, A. A. Velayati (Tehran, Iran). Lymphopenia as a mortality predictor in non HIV pulmonary TB patients. Eur Respir J 2004; 24: Suppl. 48, 2611

Member's Comments

No comment yet.

Related content which might interest you: Analysis of mortality incidence in patients with pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 555s Year: 2002 Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 A prediction rule to stratify mortality risk of patients with pulmonary tuberculosis Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016 Prognosis and predictors for mortality in patients with tuberculosis destroyed lung Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Predictors of death in patients with MDR-TB and HIV Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Characteristics and predictors of mortality in patients with pleural infection Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Fenofibrate is associated with higher risk of mortality in patients with tuberculosis infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 The assessment of risk factors and treatment of pulmonary TB relapses Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006 Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Smoking as a risk factor mortality in pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 191s Year: 2004 Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with advanced HIV disease Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Impact of seasons on tuberculosis mortality for HIV+ and HIV- TB patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2 Source: Eur Respir J, 56 (3) 2002439; 10.1183/13993003.02439-2020 Year: 2020 Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2 Source: Eur Respir J, 56 (3) 2002961; 10.1183/13993003.02961-2020 Year: 2020 Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Prevalence of pulmonary arterial hypertension in HIV positive outpatients in the HAART era Source: Eur Respir J 2006; 28: Suppl. 50, 545s Year: 2006